Unknown PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT06244056

Stellate Ganglion Block as Novel Treatment for Heart Failure Patients

Sponsor: Mina sobhi said fam

Updated 5 times since 2024 Last updated: Feb 2, 2024 Started: Feb 5, 2024 Primary completion: Jan 1, 2025 Completion: Jan 1, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Stellate Ganglion Block and is currently ongoing. Mina sobhi said fam leads this study, which shows 5 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Mar 2026 — Present [monthly]

Unknown PHASE2/PHASE3

Status: Recruiting → Unknown
Sep 2025 — Mar 2026 [monthly]

Recruiting PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Recruiting PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Mar 2024 — Jul 2024 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Feb 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mina sobhi said fam

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Asyut, Egypt